Commentary: Sodium Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Hospitalization in Patients With Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Bibliographic Details
Main Authors:	Mei Qiu, Liang-Liang Ding, Ze-Lin Zhan, Hai-Rong Zhou
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Endocrinology
Subjects:	SGLT2 inhibitors (gliflozins) type 2 diabetes (clinical domain) heart failure - pharmacological treatment - systolic dysfunction cardiovascular death all-cause death
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2021.664502/full

Internet